1-10 of 10
Mathieu Sauvezie
Close
Sort by
Journal Articles

CPX-351 Induces Deep Response and Suppress the Impact of Poor Prognosis Mutations ( TP53, ASXL1, RUNX1 and EVI1 ) Defined By ELN-2017 in t-AML and MRC AML: A Report from a Multicentric French Cohort

Edmond Chiche, Sarah Bertoli, MD PhD, Ramy Rahmé, MD, Jean Baptiste Micol, Florence Pasquier, MD PhD, Pierre Peterlin, Patrice Chevallier, MD, Xavier Thomas, MD PhD, Michael Loschi, MD PhD, Alexis Genthon, Olivier Legrand, MD PhD, Mohamad Mohty, MD PhD, Emmanuel Raffoux, MD, Patrick Auberger, PhD, Alexis Caulier, MD, Magalie Joris, MD, Caroline Bonmati, Gabrielle Roth Guepin, Mathieu Sauvezie, Caroline Lejeune, Arnaud Pigneux, Christian Recher, MD PhD, Lionel Ades, MD PhD, Thomas Cluzeau, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1355.
https://doi.org/10.1182/blood-2019-125623
Published: 2019
Journal Articles

High Incidence of HHV-6 Infection Associated with Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) Conditioning Regimen: Results of a Monocentric and Retrospective Study

Simon Favre, Mathieu Sauvezie, Marie Sarah Dilhuydy, MD, Stéphane Vigouroux, Reza Tabrizi, Gaelle Laboure, Margot Robles, noel-Jean Milpied, MD, Krimo Bouabdallah, MD
Journal: Blood
Blood (2016) 128 (22): 5817.
https://doi.org/10.1182/blood.V128.22.5817.5817
Published: 2016
Journal Articles

Comparable Immune Reconstitution Between Ex Vivo Amplification and Un-Manipulated Umbilical Cord Blood Transplantation

Edouard Forcade, Céline Cognet, Xavier Sicard, Sophie Daburon, Pascale Duchez, Zoran Ivanovic, Vincent Pitard, Julie Déchanet-Merville, Emmanuel Clave, Antoine Toubert, Stephane Vigouroux, Reza Tabrizi, Mathieu Sauvezie, Arnaud Pigneux, Jean-Francois Moreau, Noel Milpied, Jean-Luc Taupin
Journal: Blood
Blood (2015) 126 (23): 1936.
https://doi.org/10.1182/blood.V126.23.1936.1936
Published: 2015
Journal Articles

Clofarabine Combinations in Adults with Refractory/Relapsed Acute Lymphoblastic Leukemia (ALL): A GRAALL Report

Arnaud Pigneux, MD, PhD, Mathieu Sauvezie, Norbert Vey, MD, Emmanuel Raffoux, MD, PhD, Ambroise Marcais, MD, Françoise Huguet, MD, Philippe Rousselot, MD, PhD, Jean Pierre Marolleau, MD, Stéphane Leprêtre, MD, Pascal Turlure, Patrice Chevallier, MD, Mathilde Hunault, MD, PhD, Caroline Bonmati, MD, Thomas Cluzeau, Thibaut Leguay, MD, Norbert Ifrah, Herve Dombret
Journal: Blood
Blood (2011) 118 (21): 2586.
https://doi.org/10.1182/blood.V118.21.2586.2586
Published: 2011
Journal Articles

Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective Trial

Noel Milpied, MD, Bernard Dazey, MD, Zoran Ivanovic, MD PHD, Pascale Duchez, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Marie-Sarah Dilhuydy, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Mathieu Sauvezie, Xavier Lafarge, MD, Gerald Marit, MD, PhD, Jean-Michel Boiron, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 486.
https://doi.org/10.1182/blood.V118.21.486.486
Published: 2011
Journal Articles

No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial

Noel-Jean Milpied, MD, Steven Legouill, Thierry Lamy, Vincent Delwail, Remy Gressin, MD, Denis Guyotat, Gandhi Damaj, MD, Charles Foussard, MD, Philippe Quittet, MD, Herve Maisonneuve, MD, Eric Deconinck, Francois Dreyfus, MD, Emmanuel Gyan, MD, PhD, Laurent Sutton, Nadine Morineau, MD, Magda Alexis, MD, Frederic Perry, Mathieu Sauvezie
Journal: Blood
Blood (2010) 116 (21): 685.
https://doi.org/10.1182/blood.V116.21.685.685
Published: 2010
Journal Articles

Allograft After Pediatric-Inspired Therapy Does Not Improve Young patient's Outcome with High Risk Philadelphia- Chromosome-Negative Acute Lymphoblastic Leukemia (Ph-ALL). A Single Center Report

Thibaut Leguay, Service, d'Hématologie, clinique, et, thérapie, cellulaire, Arnaud Pigneux, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Reza Tabrizi, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Mathieu Sauvezie, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Krimo Bouabdallah, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Marie-Sarah Dilhuydy, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Axelle Lascaux, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Carine Foucaud, Anna Schmitt, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Stephane Vigouroux, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Gerald Marit, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, noel-Jean Milpied, Service, d'hématologie, clinique, et, de, thérapie, cellulaire
Journal: Blood
Blood (2010) 116 (21): 3528.
https://doi.org/10.1182/blood.V116.21.3528.3528
Published: 2010
Journal Articles

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

Noel-Jean Milpied, MD, Gerald Marit, Bernard Dazey, Jean-Michel Boiron, MD, PhD, Zoran Ivanovic, Carine Foucaud, Fontanet Bijou, Krimo Bouabdallah, MD, Anna Schmitt, Mathieu Sauvezie, Christian Cailliot, MD, Josy Reiffers
Journal: Blood
Blood (2009) 114 (22): 502.
https://doi.org/10.1182/blood.V114.22.502.502
Published: 2009
Journal Articles

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Anna Schmitt, Reza Tabrizi, MD, Stephane Vigouroux, Mathieu Sauvezie, Carine Foucaud, Krimo Bouabdallah, marie-Sarah Dilhuydy, Arnaud Pigneux, MD, PhD, Thibaut Leguay, didier-Innocent Adiko, Jean-Michel Boiron, MD, PhD, Gerald Marit, Noel-Jean Milpied, PhD
Journal: Blood
Blood (2008) 112 (11): 4310.
https://doi.org/10.1182/blood.V112.11.4310.4310
Published: 2008
Journal Articles

Improved Outcome by Addition of Lomustine (CCNU) to Idarubicin and Cytarabine in Elderly Patients with De Novo Acute Myeloid Leukemia. A Report from the GOELAMS Group

Arnaud Pigneux, MD, PhD, Francis Witz, Mathieu Sauvezie, Marie-Christine Bene, MD, PhD, Isabelle Luquet, MD, PhD, Mathilde hunault-Berger, MD, PhD, Christian Recher, M.D., Ph.D, Norbert Vey, MD, Bruno Lioure, MD, Chantal Himberlin, MD, Martine Escoffre-Barbe, MD, Christian Berthou, Severine Lissandre, Nathalie Fegueux, MD, Jean-Yves Cahn, MD, PhD, Eric Jourdan, MD, PhD, Didier Bouscary, MD, PhD, Francois Dreyfus, Josy M. Reiffers, Noel Milpied, MD, Jean-Luc Harousseau, MD, Norbert Ifrah, MD
Journal: Blood
Blood (2008) 112 (11): 761.
https://doi.org/10.1182/blood.V112.11.761.761
Published: 2008